Literature DB >> 1924796

Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study.

C R Rees1, J C Palmaz, G J Becker, K O Ehrman, G M Richter, G Noeldge, B T Katzen, M D Dake, D E Schwarten.   

Abstract

Palmaz balloon-expandable stents were placed in 28 hypertensive patients with atherosclerosis involving the ostia of the renal arteries. Stents were placed to treat elastic recoil immediately after conventional angioplasty in 20 patients and restenosis after percutaneous transluminal angioplasty in eight patients. Technical success (greater than 30% residual stenosis) was achieved in 27 patients. Complications occurred in five patients. At follow-up (1-25 months), hypertension was cured in three patients and improved in 15 patients, with a cumulative cure or improvement of 64% at 6 months. Of 14 patients with a serum creatinine level of 1.5 mg/dL (132.6 mumol/L) or greater before the placement of stents, five demonstrated improved renal function, five showed stabilization of their condition, and four demonstrated deterioration. Follow-up angiography (2-18 months) was performed in 18 patients. Restenosis was present in seven patients and was accompanied by a relapse of hypertension in only three patients. Of the other four patients with restenosis, two had no initial improvement and two had an initial response without a relapse of hypertension. In this preliminary study, renal stents were beneficial in many patients with poor results from conventional angioplasty for ostial atheroma.

Entities:  

Mesh:

Year:  1991        PMID: 1924796     DOI: 10.1148/radiology.181.2.1924796

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Management of atherosclerotic renovascular disease: the effect of renal artery stenting on renal function and blood pressure.

Authors:  Kosmas I Paraskevas; Despina Perrea; Despina D Briana; Christos D Liapis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  Stent revascularization for atherosclerotic renal artery stenosis. 1-year clinical follow-up.

Authors:  G Dorros; M R Jaff; L Mathiak; I I Dorros; A Lowe; K Murphy; T He
Journal:  Tex Heart Inst J       Date:  1998

3.  Atherosclerotic Renal Artery Stenosis.

Authors:  Robert D. Safian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

Review 4.  Atherosclerotic renal artery stenosis: from diagnosis to treatment.

Authors:  P Carmichael; A R Carmichael
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

5.  Endovascular stents in arterial injury after radiotherapy.

Authors:  P Liu; P Perreault; P Otal; D Colombier; J P Berregi; C Bastide; J P Cercueil; D Krause; H Rousseau; F Joffre
Journal:  J Tongji Med Univ       Date:  1998

6.  Percutaneous transluminal angioplasty for atherosclerotic stenosis of the subclavian or innominate artery: angiographic and clinical outcomes in 36 patients.

Authors:  Akinori Miyakoshi; Taketo Hatano; Tetsuya Tsukahara; Mamoru Murakami; Daisuke Arai; Susumu Yamaguchi
Journal:  Neurosurg Rev       Date:  2011-06-04       Impact factor: 3.042

7.  Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patients.

Authors:  P M Pattynama; G J Becker; J Brown; G Zemel; J F Benenati; B T Katzen
Journal:  Cardiovasc Intervent Radiol       Date:  1994 May-Jun       Impact factor: 2.740

Review 8.  Drug-eluting stents in renal artery stenosis.

Authors:  M Zähringer; P M T Pattynama; A Talen; M Sapoval
Journal:  Eur Radiol       Date:  2007-10-11       Impact factor: 5.315

9.  First use of cryoplasty to treat in-stent renal artery restenosis.

Authors:  John L Jefferies; Kathryn Dougherty; Zvonimir Krajcer
Journal:  Tex Heart Inst J       Date:  2008

Review 10.  Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases.

Authors:  Kai König; Jutta Gellermann; Uwe Querfeld; Martin B E Schneider
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.